OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc.
A complete breakdown of APCM billing codes G0556, G0557, and G0558 - eligibility requirements, reimbursement rates, and ...
MedPage Today on MSN
Should Doctors Charge Patients for Prior Authorization?
Between one-off charges, administrative fees, and office visit copays, some are trying ...
APCM vs. CCM: what every primary care practice needs to know before switching; rates, rules, revenue impact, and who ...
Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...
Intrinsic Therapeutics, Inc. has introduced the Barricaid ® Narrow Anchor, the next generation of its FDA PMA-approved ...
In part 2 of this article, we describe the growing importance of artificial intelligence tools in evaluation and management (E&M) services. We emphasize the importance of physicians proactively ...
Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals ...
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today ...
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
Sera Prognostics, Inc.: Sera Prognostics Reports Fourth Quarter And Full Year 2025 Financial Results
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing ...
Baystreet.ca News Commentary — The global precision oncology market is on pace to reach $303 billion in 2035[1], a figure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results